Anti-proliferative, Anti-angiogenic and Anti-inflammatory Effects of Moringa peregrina Leaf Extracts on Testosterone- Induced Benign Prostatic Hyperplasia in Rats

Asian Pac J Cancer Prev. 2022 Jan 1;23(1):161-169. doi: 10.31557/APJCP.2022.23.1.161.

Abstract

Aim: To investigate the potential anti-inflammatory and biochemical effects of Moringa peregrina leaf extracts on testosterone-induced benign prostatic hyperplasia (BPH) in rats.

Methods: Six groups of rats (each group included 5 rats) were included in this study. The groups included: 1) the control group, 2) the testosterone-induced BPH group, 3) with 50 mg/kg bwt (bodyweight) oil-treated BPH, 4) with 100 mg/kg bwt. oil-treated BPH, 5) with 500mg/kg bwt. ethanol treated BPH and 6) with 1,000 mg/kg bwt. aqueous treated BPH group. Biochemical markers were measured to evaluate the effect of M. peregrina leaf extracts.

Results: Our results showed a significant improvement in the thickness of epithelial cells of the BPH glandular tissues when treated with different M. peregrina extracts (p < 0.05). In addition, M. peregrina extracts showed anti-inflammatory, anti-proliferative and anti-angiogenesis effects on the BPH tissues by reduction of IL-6, PCNA and VEGF-A, respectively.

Conclusion: Our preclinical study concluded that M. peregrina leaf extracts showed a significant effect on BPH by reducing inflammation, proliferation, and angiogenic processes with no signs of toxicity.

Keywords: Anti-angiogenesis; Anti-proliferation; M. peregrina; anti-inflammation; benign prostatic hyperplasia.

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Cell Proliferation / drug effects*
  • Disease Models, Animal
  • Male
  • Moringa*
  • Plant Extracts / pharmacology*
  • Plant Leaves
  • Prostatic Hyperplasia / chemically induced
  • Prostatic Hyperplasia / drug therapy*
  • Rats
  • Testosterone

Substances

  • Angiogenesis Inhibitors
  • Anti-Inflammatory Agents
  • Plant Extracts
  • Testosterone